Generic Drugs

The generic drug is bioequivalent to the branded product, meaning there is either no significant difference between the two drugs in terms of the rate and extent of absorption or if there is a difference, it is either intended or not medically significant. According to guidelines from the United States Food and Drug Administration (FDA), the generic drug must have the same active ingredient as the brand name drug as well as the same dosage, strength, safety, conditions of use and route of administration.


  • Clinical Therapeutics
  • Adverse drug reactions
  • Drug Toxicology
  • Antidotes
  • Anti cancer drugs
  • Anti diabetic drugs
  • Life saving drugs
  • Innovation in generics: is it applicable?
  • Generic market: Patent expiration of a host of Blockbuster drugs in the next 5 years versus austerity measures through Europe in the health sector
  • Innovation in Generics, a way to maintain the growth
  • Global Generic Trends
  • Generic Pills and Generic Medication

Related Conference of Generic Drugs

Generic Drugs Conference Speakers